An Anti-Inflammatory PPAR-γ Agonist from the Jellyfish-Derived Fungus Penicillium chrysogenum J08NF-4

Autor: Mingzhi Su, Jongki Hong, Sen Liu, Hae Young Chung, Jee H. Jung, Shao-Jiang Song
Rok vydání: 2018
Předmět:
Agonist
Scyphozoa
medicine.drug_class
Interleukin-1beta
Anti-Inflammatory Agents
Nitric Oxide Synthase Type II
Pharmaceutical Science
Peroxisome proliferator-activated receptor
Penicillium chrysogenum
01 natural sciences
Cell Line
Analytical Chemistry
Mice
chemistry.chemical_compound
Drug Discovery
medicine
Animals
RAW 264.7 Cells
Inflammation
Pharmacology
Meroterpene
chemistry.chemical_classification
biology
Interleukin-6
Tumor Necrosis Factor-alpha
010405 organic chemistry
Chemistry
Macrophages
Organic Chemistry
NF-kappa B
Transcription Factor RelA
biology.organism_classification
Molecular biology
0104 chemical sciences
PPAR gamma
010404 medicinal & biomolecular chemistry
Complementary and alternative medicine
Cyclooxygenase 2
Cell culture
Molecular Medicine
Phosphorylation
lipids (amino acids
peptides
and proteins)

Inflammation Mediators
Signal transduction
Signal Transduction
Zdroj: Journal of Natural Products. 81:356-363
ISSN: 1520-6025
0163-3864
Popis: An investigation of the jellyfish-derived fungus Penicillium chrysogenum J08NF-4 led to the isolation of two new meroterpene derivatives, chrysogenester (1) and 5-farnesyl-2-methyl-1-O-methylhydroquinone (2), and four known farnesyl meroterpenes. Docking analysis of 1 showed that it binds to PPAR-γ in the same manner as the natural PPAR-γ agonist amorfrutin B (7). Compound 1 activated PPAR-γ in murine Ac2F liver cells and increased nuclear PPAR-γ protein levels in murine RAW 264.7 macrophages. Because one of the main biological functions of PPAR-γ agonists is to suppress inflammatory response, an in vitro study was performed to explore the anti-inflammatory potency of 1 and the mechanism involved. In RAW 264.7 macrophages, 1 inhibited phosphorylation of the NF-κB p65 subunit and suppressed the expression of the pro-inflammatory mediators iNOS, NO, COX-2, TNF-α, IL-1β, and IL-6. We propose 1 suppresses inflammatory responses by activating PPAR-γ and subsequently downregulating the NF-κB signaling pathway, thus reducing the expressions of pro-inflammatory mediators.
Databáze: OpenAIRE